VITASPRING BIOMEDICAL CO., LTD. Net Investment Income
VITASPRING BIOMEDICAL CO., LTD. (VSBC) reported Net Investment Income of $5.76 thousand for the 9-month period ending 2022-10-31, per its 10-Q filed 2022-12-21.
Discontinued › Income Statement › Other Income
us-gaap:NetInvestmentIncome · last filed 2022-12-21
- VITASPRING BIOMEDICAL CO., LTD. net investment income for the quarter ending 2022-10-31 was -$126.76K.
- VITASPRING BIOMEDICAL CO., LTD. net investment income for the quarter ending 2022-07-31 was -$144.13K, a 175.79% decline year-over-year.
- VITASPRING BIOMEDICAL CO., LTD. net investment income for the quarter ending 2022-04-30 was $276.66K, a 17.40% increase year-over-year.
- VITASPRING BIOMEDICAL CO., LTD. net investment income for the quarter ending 2022-01-31 was -$941.37K, a 372.29% decline year-over-year.
- VITASPRING BIOMEDICAL CO., LTD. net investment income for fiscal 2022 was -$1.26M, a 397.15% decline from fiscal 2021.
- VITASPRING BIOMEDICAL CO., LTD. net investment income for fiscal 2021 was $425.38K.
| Period end | Net Investment Income 3 month | Net Investment Income 6 month | Net Investment Income 9 month | Net Investment Income 12 month |
|---|---|---|---|---|
| 2022-10-31 | -$126.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-12-21 | -$270.90K derived: sum of 2 quarters · filed 2022-12-21 | $5.76K 10-Q · filed 2022-12-21 | -$935.61K derived: sum of 4 quarters · filed 2022-12-21 |
| 2022-07-31 | -$144.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-09-15 | $132.52K 10-Q · filed 2022-09-15 | -$808.85K derived: sum of 3 quarters · filed 2022-09-15 | -$1.56M derived: sum of 4 quarters · filed 2022-12-21 |
| 2022-04-30 | $276.66K 10-Q · filed 2022-06-15 | -$664.72K derived: sum of 2 quarters · filed 2022-06-15 | -$1.41M derived: sum of 3 quarters · filed 2022-12-21 | -$1.22M derived: sum of 4 quarters · filed 2022-12-21 |
| 2022-01-31 | -$941.37K derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-03 | -$1.69M derived: sum of 2 quarters · filed 2022-12-21 | -$1.50M derived: sum of 3 quarters · filed 2022-12-21 | -$1.26M 10-K · filed 2022-05-03 |
| 2021-10-31 | -$748.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-12-21 | -$558.29K derived: sum of 2 quarters · filed 2022-12-21 | -$322.63K 10-Q · filed 2022-12-21 | $23.10K derived: sum of 4 quarters · filed 2022-12-21 |
| 2021-07-31 | $190.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-09-15 | $425.84K 10-Q · filed 2022-09-15 | $771.57K derived: sum of 3 quarters · filed 2022-09-15 | $959.58K derived: sum of 4 quarters · filed 2022-09-15 |
| 2021-04-30 | $235.66K 10-Q · filed 2022-06-15 | $581.39K derived: sum of 2 quarters · filed 2022-06-15 | $769.40K derived: sum of 3 quarters · filed 2022-06-15 | |
| 2021-01-31 | $345.73K derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-03 | $533.74K derived: sum of 2 quarters · filed 2022-05-03 | $425.38K 10-K · filed 2022-05-03 | |
| 2020-10-31 | $188.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-12-23 | $79.65K 10-Q · filed 2021-12-23 | ||
| 2020-07-31 | -$108.36K 10-Q · filed 2021-09-15 |